0001209191-23-016739.txt : 20230307
0001209191-23-016739.hdr.sgml : 20230307
20230307162438
ACCESSION NUMBER: 0001209191-23-016739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shabbir Anik
CENTRAL INDEX KEY: 0001751728
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 23712942
BUSINESS ADDRESS:
STREET 1: 310 UTAH AVE, STE. 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 310 UTAH AVE, STE. 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-03
0
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001751728
Shabbir Anik
C/O SUTRO BIOPHARMA, INC
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Technical Ops. Officer
Common Stock
2023-03-03
4
M
0
7875
A
38299
D
Common Stock
2023-03-03
4
M
0
8750
A
47049
D
Common Stock
2023-03-03
4
F
0
6222
5.79
D
40827
D
Restricted Stock Unit (RSU)
2023-03-03
4
A
0
40000
0.00
A
2025-03-01
Common Stock
40000
40000
D
Restricted Stock Unit (RSU)
2023-03-03
4
M
0
7875
0.00
D
2026-03-04
Common Stock
7875
23625
D
Restricted Stock Unit (RSU)
2023-03-03
4
M
0
8750
0.00
D
2025-03-05
Common Stock
8750
17500
D
Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
The RSUs vest as to 1/2 of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Shabbir Anik
2023-03-07